Stock Research for APNHY


Featured Broker: Ally Invest

Get the due diligence for another stock.


APNHY Stock Chart & Research Data

The APNHY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the APNHY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


APNHY Due diligence Resources & Stock Charts

The APNHY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View APNHY Detailed Price Forecast - CNN Money CNN View APNHY Detailed Summary - Google Finance
Yahoo View APNHY Detailed Summary - Yahoo! Finance Zacks View APNHY Stock Research & Analysis -

Stock Analysis

TradeIdeas View APNHY Trends & Analysis - Trade-Ideas Barrons View APNHY Major Holders - Barrons
NASDAQ View APNHY Call Transcripts - NASDAQ Seeking View APNHY Breaking News & Analysis - Seeking Alpha
Spotlight View APNHY Annual Report - OTC Report View APNHY OTC Short Report -
TradeKing View APNHY Fundamentals - TradeKing Charts View APNHY SEC Filings - Bar Chart
WSJ View Historical Prices for APNHY - The WSJ Morningstar View Performance/Total Return for APNHY - Morningstar
MarketWatch View the Analyst Estimates for APNHY - MarketWatch CNBC View the Earnings History for APNHY - CNBC
StockMarketWatch View the APNHY Earnings - StockMarketWatch MacroAxis View APNHY Buy or Sell Recommendations - MacroAxis
Bullish View the APNHY Bullish Patterns - American Bulls Short Pains View APNHY Short Pain Metrics -

Social Media Mentions

StockTwits View APNHY Stock Mentions - StockTwits PennyStocks View APNHY Stock Mentions - PennyStockTweets
Twitter View APNHY Stock Mentions - Twitter Invest Hub View APNHY Investment Forum News - Investor Hub
Yahoo View APNHY Stock Mentions - Yahoo! Message Board Seeking Alpha View APNHY Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for APNHY - Insider Cow View Insider Transactions for APNHY - Insider Cow
CNBC View APNHY Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for APNHY - OTC Markets
Yahoo View Insider Transactions for APNHY - Yahoo! Finance NASDAQ View Institutional Holdings for APNHY - NASDAQ

Stock Charts

FinViz View APNHY Stock Insight & Charts - StockCharts View APNHY Investment Charts -
BarChart View APNHY Stock Overview & Charts - BarChart Trading View View APNHY User Generated Charts - Trading View

Latest Financial News for APNHY

Aspen Pharmacare Holdings Ltd. : Neutral assessment on price but strong on fundamentals
Posted on Wednesday December 13, 2017

Categories: Yahoo FinanceAspen Pharmacare Holdings Ltd. relative valuation is now NEUTRAL. It was previously rated OVERVALUED, and has a fundamental analysis score of 63. Our analysis is based on comparing Aspen Pharmacare Holdings Ltd. with the following peers – Merck & Co., Inc., Pfizer Inc., Mylan N.V., Johnson & Johnson, Dr. Reddy’s Laboratories Ltd. Sponsored ADR, Teva ... Read more (Read more...)

Mylan and Aspen Announce Launch of Generic Busulfex® Injection
Posted on Monday December 04, 2017

HERTFORDSHIRE, England, PITTSBURGH and DURBAN, South Africa, Dec. 4, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) and its partner, Aspen (JSE:APN), today announced the U.S. launch of Myleran (busulfan) Injection, 60 mg/10 mL (6 mg/mL) Single-dose Vial, a generic version of Otsuka Pharmaceutical's Busulfex® Injection. Aspen received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia. As part of its partnership with Aspen, Mylan will commercialize Busulfan Injection, 60 mg/10 mL (6 mg/mL) Single-dose Vial in the U.S. Mylan has one of the largest injectable portfolios in the industry and is also one of the largest suppliers of cancer medicines by volume in the U.S.

ETFs with exposure to Aspen Pharmacare Holdings Ltd. : November 13, 2017
Posted on Monday November 13, 2017

Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Aspen Pharmacare Holdings Ltd. Here are 5 ETFs with the largest exposure to APNHY-US. Comparing the performance and risk of Aspen Pharmacare Holdings Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

Posted on Wednesday December 31, 1969

Stock Market & Investing Books

Enter a stock symbol to view the stock details.